A Randomized Controlled Trial of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Sepsis Due to Melioidosis in Thailand
Open Access
- 1 August 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (3) , 308-314
- https://doi.org/10.1086/519261
Abstract
Background. Melioidosis is a tropical infectious disease associated with significant mortality. Most deaths occur early and are caused by fulminant sepsis.Keywords
This publication has 25 references indexed in Scilit:
- Adjunctive Granulocyte Colony‐Stimulating Factor for Treatment of Septic Shock Due to MelioidosisClinical Infectious Diseases, 2004
- Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis*Critical Care Medicine, 2003
- Endemic Melioidosis in Tropical Northern Australia: A 10‐Year Prospective Study and Review of the LiteratureClinical Infectious Diseases, 2000
- Risk Factors for Melioidosis and Bacteremic MelioidosisClinical Infectious Diseases, 1999
- Comparison of Imipenem and Ceftazidime as Therapy for Severe MelioidosisClinical Infectious Diseases, 1999
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- Prevalence of Endemic Distal Renal Tubular Acidosis and Renal Stone in the Northeast of ThailandNephron, 1996
- FilgrastimDrugs, 1994
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- APACHE IICritical Care Medicine, 1985